293 related articles for article (PubMed ID: 18577708)
1. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
Rand JH; Wu XX; Quinn AS; Chen PP; Hathcock JJ; Taatjes DJ
Blood; 2008 Sep; 112(5):1687-95. PubMed ID: 18577708
[TBL] [Abstract][Full Text] [Related]
2. A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes.
Bezati E; Wu XX; Quinn AS; Taatjes DJ; Rand JH
Lupus; 2015 Jan; 24(1):32-41. PubMed ID: 25139939
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
Rand JH; Wu XX; Quinn AS; Ashton AW; Chen PP; Hathcock JJ; Andree HA; Taatjes DJ
Blood; 2010 Mar; 115(11):2292-9. PubMed ID: 19965621
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies.
Marchetti T; Ruffatti A; Wuillemin C; de Moerloose P; Cohen M
J Thromb Haemost; 2014 Jun; 12(6):910-20. PubMed ID: 24656088
[TBL] [Abstract][Full Text] [Related]
7. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
[TBL] [Abstract][Full Text] [Related]
8. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
9. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.
Tanimura K; Jin H; Suenaga T; Morikami S; Arase N; Kishida K; Hirayasu K; Kohyama M; Ebina Y; Yasuda S; Horita T; Takasugi K; Ohmura K; Yamamoto K; Katayama I; Sasazuki T; Lanier LL; Atsumi T; Yamada H; Arase H
Blood; 2015 Apr; 125(18):2835-44. PubMed ID: 25733579
[TBL] [Abstract][Full Text] [Related]
10. The J-elongated conformation of β
Ruben E; Planer W; Chinnaraj M; Chen Z; Zuo X; Pengo V; De Filippis V; Alluri RK; McCrae KR; Macor P; Tedesco F; Pozzi N
J Biol Chem; 2020 Jul; 295(31):10794-10806. PubMed ID: 32518155
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
Dong Y; Lu Y; Xia Y; Wang X
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
13. Inverted erythrocyte membranes demonstrate β2GPI-antiphospholipid antibody interactions and membrane crosslinking.
Bloemen S; Wu XX; Devreese KM; de Laat B; Rand JH; Vasovic LV
Thromb Res; 2016 Oct; 146():89-94. PubMed ID: 27622308
[TBL] [Abstract][Full Text] [Related]
14. The antiphospholipid syndrome: still an enigma.
Chaturvedi S; McCrae KR
Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
[TBL] [Abstract][Full Text] [Related]
15. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.
Wu XX; Guller S; Rand JH
Am J Obstet Gynecol; 2011 Dec; 205(6):576.e7-14. PubMed ID: 21871597
[TBL] [Abstract][Full Text] [Related]
17. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.
Atsumi T; Amengual O; Yasuda S; Matsuura E; Koike T
Autoimmunity; 2005 Aug; 38(5):377-81. PubMed ID: 16227153
[TBL] [Abstract][Full Text] [Related]
18. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
19. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome.
Liu J; Zhang L; Tian Y; Wan S; Hu M; Song S; Zhang M; Zhou Q; Xia Y; Wang X
J Cell Mol Med; 2022 Aug; 26(15):4357-4370. PubMed ID: 35770338
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
